Author

Seoyeon Min

Observed name: MIN, SEOYEON

Institution: Ewha Womans University Mokdong Hospital

Observed institutions: Ewha Womans University, Seoul National University, Ewha Womans University Mokdong Hospital

ORCID: 0000-0002-5856-7603

Observed ORCID: 0000-0002-5856-7603

OpenAlex ID: A5003846614

An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts

2016 · Sung-Yup Cho, Wonyoung Kang, et al. · Molecules and Cells · 151

Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer

2015 · Hansoo Park, Sung-Yup Cho, et al. · Proceedings of the National Academy of Sciences · 65

Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts

2021 · Deukchae Na, Jeesoo Chae, et al. · Nature Communications · 56

CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers

2021 · Hae Rim Jung, Yumi Oh, et al. · Oncogene · 30

Prediction of Patient Drug Response via 3D Bioprinted Gastric Cancer Model Utilized Patient‐Derived Tissue Laden Tissue‐Specific Bioink

2025 · Yoo‐mi Choi, Deukchae Na, et al. · Advanced Science · 21

Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers

2019 · Sung-Yup Cho, Jeesoo Chae, et al. · Clinical Cancer Research · 21

A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF -mutated and BCL2L1 -amplified Colorectal Cancers

2017 · Sung-Yup Cho, Jee Yun Han, et al. · Molecular Cancer Therapeutics · 18

Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancers

2020 · Yumi Oh, Hae Rim Jung, et al. · Cancer Letters · 17

Alterations in the Rho pathway contribute to Epstein-Barr virus–induced lymphomagenesis in immunosuppressed environments

2018 · Sung-Yup Cho, Chang Ohk Sung, et al. · Blood · 14

Prediction of Patient Drug Response via 3D Bioprinted Gastric Cancer Model Utilized Patient‐Derived Tissue Laden Tissue‐Specific Bioink (Adv. Sci. 10/2025)

2025 · Yoo‐mi Choi, Deukchae Na, et al. · Advanced Science

Supplementary Table S1 from A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers

2023 · Sung-Yup Cho, Jee Yun Han, et al.

Supplementary Table S3 from A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers

2023 · Sung-Yup Cho, Jee Yun Han, et al.

Supplementary Table S2 from A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers

2023 · Sung-Yup Cho, Jee Yun Han, et al.

Supplementary Table S4 from A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers

2023 · Sung-Yup Cho, Jee Yun Han, et al.

Supplementary Figures from A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers

2023 · Sung-Yup Cho, Jee Yun Han, et al.

Supplementary Table S1 from A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers

2023 · Sung-Yup Cho, Jee Yun Han, et al.

Supplementary Table S2 from A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers

2023 · Sung-Yup Cho, Jee Yun Han, et al.

Supplementary Table S4 from A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers

2023 · Sung-Yup Cho, Jee Yun Han, et al.

Supplementary Figures from A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers

2023 · Sung-Yup Cho, Jee Yun Han, et al.

Supplementary Table S3 from A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers

2023 · Sung-Yup Cho, Jee Yun Han, et al.

Data from A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers

2023 · Sung-Yup Cho, Jee Yun Han, et al.

Data from A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers

2023 · Sung-Yup Cho, Jee Yun Han, et al.

Supplementary Materials from Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers

2023 · Sung-Yup Cho, Jeesoo Chae, et al.

Supplementary Materials from Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers

2023 · Sung-Yup Cho, Jeesoo Chae, et al.

Data from Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers

2023 · Sung-Yup Cho, Jeesoo Chae, et al.

Works count: 29

Citation count: 393

H-index: 9

I10-index: 9